Phosphatidylserine Market Reaching USD 241.6 Mn by 2034

Overview

New York, NY – June 09, 2025 – The Global Phosphatidylserine Market is experiencing steady growth, with its size expected to reach USD 241.6 million by 2034, up from USD 158.6 million in 2024, growing at a CAGR of 4.3% during the 2025–2034 forecast period.

In 2024, Conventional phosphatidylserine dominated the market, securing over 94.6% of the total share. Its dominance stems from well-established, cost-effective extraction methods using soy and other plant-based sources, ensuring reliability and consistent quality. Plant-based phosphatidylserine led the market in 2024, capturing a 74.8% share. Driven by consumer demand for sustainable, natural ingredients, soy and sunflower lecithin remain the primary sources.

Phosphatidylserine in Powder form held a 65.9% market share, driven by its versatility for use in capsules, tablets, and functional foods. Dietary supplements accounted for 45.2% of the phosphatidylserine market in 2024, fueled by growing consumer awareness of cognitive health, memory enhancement, and stress relief benefits. Offline distribution channels dominated in 2024, holding a 76.4% market share. Pharmacies, health stores, and specialty retailers remain preferred due to consumer trust in physical product inspection and expert advice.

Key Takeaways

• Phosphatidylserine Market size is expected to be worth around USD 241.6 million by 2034, from USD 158.6 million in 2024, growing at a CAGR of 4.3%.
• Conventional phosphatidylserine held a dominant market position, capturing more than a 94.6% share.
• Plant-based phosphatidylserine held a dominant market position, capturing more than a 74.8% share.
• Powder form of phosphatidylserine held a dominant market position, capturing more than a 65.9% share.
• Dietary supplements held a dominant market position in the phosphatidylserine industry, capturing more than a 45.2% share.
• Offline distribution held a dominant market position in the phosphatidylserine market, capturing more than a 76.4% share.
• North America emerged as the leading region in the global phosphatidylserine market, commanding a substantial share of 42.9%, translating to approximately USD 68.0 million.

How Growth is Impacting the Economy

• The Phosphatidylserine Market’s growth significantly impacts the economy by driving job creation in manufacturing, R&D, and retail sectors. The market’s expansion boosts demand for plant-based raw materials like soy and sunflower, benefiting agricultural economies. Increased production scales up supply chains, enhancing logistics and distribution networks.
• Rising consumer spending on dietary supplements stimulates retail, both offline and online, fostering e-commerce growth. Additionally, innovation in extraction technologies spurs investment in biotech, creating high-skill jobs. Regulatory approvals enhance market stability, attracting foreign investments, particularly in North America, which held a USD 68.0 million share in 2024, strengthening regional economies.

➤ Curious about the content? Explore a sample copy of this report – https://market.us/report/phosphatidylserine-market/request-sample/

Strategies for Businesses

• Businesses should focus on sustainable sourcing, leveraging plant-based phosphatidylserine to align with eco-conscious consumer trends. Investing in advanced extraction technologies can improve yield and purity, enhancing competitiveness. Expanding product portfolios to include powder-based supplements ensures versatility and market reach. Strengthening offline distribution channels, which held 76.4% in 2024, while optimizing e-commerce platforms, can capture diverse consumer bases. Collaborating with regulatory bodies ensures compliance and builds trust. Marketing campaigns emphasizing cognitive health benefits can target aging populations, driving demand and boosting market share.

Report Scope

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=148764

Key Market Segments

By Nature

• In 2024, Conventional phosphatidylserine dominated the market, securing over 94.6% of the total share. Its dominance stems from well-established, cost-effective extraction methods using soy and other plant-based sources, ensuring reliability and consistent quality. Manufacturers favor conventional PS for its regulatory acceptance, widespread availability, and trusted supply chains. Despite rising interest in alternative sources, conventional phosphatidylserine remains the cornerstone of the market, supporting dietary supplements and pharmaceutical applications, bolstered by government approvals and consumer confidence.

By Source

• Plant-based phosphatidylserine led the market in 2024, capturing a 74.8% share. Driven by consumer demand for sustainable, natural ingredients, soy and sunflower lecithin remain the primary sources. Advances in extraction technologies have enhanced purity and yield, while regulatory support from bodies like the U.S. FDA has strengthened trust among manufacturers and consumers. The shift toward eco-friendly, non-animal-derived products aligns with global trends, ensuring plant-based PS remains the market’s leading contributor.

By Form

• In 2024, Phosphatidylserine in Powder form held a 65.9% market share, driven by its versatility for use in capsules, tablets, and functional foods. Its advantages include a longer shelf life, precise dosage control, and cost-effective transportation. Powder PS also offers superior formulation stability compared to liquid forms, making it the top choice for supplement manufacturers globally and maintaining its market dominance.

By Application

• Dietary supplements accounted for 45.2% of the phosphatidylserine market in 2024, fueled by growing consumer awareness of cognitive health, memory enhancement, and stress relief benefits. The aging population’s demand for natural brain health solutions drove consistent growth. Easy-to-consume formats like capsules and powders, combined with regulatory support and health campaigns, solidified dietary supplements as the primary application for phosphatidylserine.

By Distribution Channel

• Offline distribution channels dominated in 2024, holding a 76.4% market share. Pharmacies, health stores, and specialty retailers remain preferred due to consumer trust in physical product inspection and expert advice. Despite e-commerce growth, offline channels benefit from personalized experiences and regulatory favorability, maintaining their lead in the phosphatidylserine market.

Regional Analysis

• North America led the global phosphatidylserine market in 2024, with a 42.9% share, equivalent to approximately USD 68.0 million. This is driven by heightened cognitive health awareness, a robust healthcare system, and growing demand for dietary supplements, particularly in the U.S. The aging population and rising concerns about cognitive decline, such as Alzheimer’s and memory impairment, fuel demand for phosphatidylserine. Accessible retail and e-commerce platforms, alongside increased consumer education, further boost the region’s market growth.

Recent Developments

1. Chemi Nutra LLC

• Chemi Nutra LLC, a leader in phosphatidylserine (PS) innovation, recently launched SerinAid, a high-purity PS derived from sunflower lecithin, catering to vegan and allergen-free markets. The company emphasizes clinical research supporting PS for cognitive health and stress reduction. Their latest studies explore PS’s role in sports nutrition and mental performance.

2. Doosan Corporation

• Doosan Corporation’s biotech division has expanded its phosphatidylserine production using non-GMO soy sources, enhancing bioavailability. Recent investments focus on large-scale fermentation techniques to improve yield and sustainability. Doosan also partners with nutraceutical brands to integrate PS into functional foods.

3. Double Wood LLC

• Double Wood Supplements released a new Phosphatidylserine + L-Theanine blend, targeting stress and focus. Their PS is soy-derived, non-GMO, and backed by third-party testing. The company highlights growing consumer demand for nootropic stacks featuring PS for memory support.

4. ECA Healthcare Inc.

• ECA Healthcare Inc. introduced NeuroPS, a patented PS formulation combined with omega-3s for enhanced absorption. Recent clinical trials suggest benefits in age-related cognitive decline. The company is expanding into Asian markets with customized PS solutions.

5. IvoVital GmbH

• IvoVital GmbH’s Ivosin PS focuses on sports recovery and mental clarity, with new research on PS’s impact on cortisol reduction. Their sunflower-based PS is marketed as a sustainable alternative, with recent EU regulatory approvals strengthening market position.

Conclusion

The Phosphatidylserine Market is popular in brain health supplements and eco-friendly plant-based sources, making it a winner. The market boosts jobs and innovation, especially in North America, which holds a strong 42.9% share. Businesses can thrive by offering versatile powder forms and targeting health-conscious consumers, ensuring phosphatidylserine remains a key player in wellness.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF